T6	Effect 83 145	recurrent eosinophilia and deterioration of pulmonary function
T7	Treatment 160 224	use of tobramycin by inhalation or by intravenous administration
T8	Subject 62 70	patients
T9	Drug 167 177	tobramycin
T10	Route 181 191	inhalation
T11	Route 199 225	ntravenous administration.
T5	Adverse_event 75 82	develop
E1	Adverse_event:T5